The China Study by Thomas Campbell
REFERENCES 383
- Heber 0, Ashley JM, LeafDA, et at. "Reduction of serum estradiol in postmenopausal women
given free access to low-fat high-carbohydrate diet." Nutrition 7 (1991): 137-139.
- Rose DP, Goldman M, Connolly JM, et al. "High-fiber diet reduces serum estrogen concentra-
tions in premenopausal women." Am.]. Clin. Nutr. 54 (1991): 520-525.
- Rose DP, Lubin M, and Connolly JM. "Efects of diet supplementation with wheat bran on
serum estrogen levels in the follicular and luteal phases of the menstrual cycle." Nutrition 13
(1997): 535-539.
- Tymchuk CN, Tessler SB, and Barnard R]. "Changes in sex hormone-binding globulin, insu-
lin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with
exercise." Nutr. Cancer 38 (2000): 158-162.
- Key TJA, ChenJ, Wang DY, et a1. "Sex hormones in women in rural China and in Britain."
Brit.]. Cancer 62 (1990): 631-636.
- Prentice R, Thompson 0 , Clifford C, et at. "Dietary fat reduction and plasma estradiol con-
centration in healthy postmenopausal women."]. Natl. Cancer Inst. 82 (1990): 129-134.
- Boyar Ap, Rose Dp, and Wynder EL. "Recommendations for the prevention of chronic disease:
the application for breast disease." Am.]. Clin. Nutr. 48(3 Suppl) (1988): 896--900.
- Nandi S, Guzman RC, and Yang]. "Hormones and mammary carcinogenesis in mice, rats and
humans: a unifying hypothesis." Proc. National Acad. Sci 92 (1995): 3650-3657.
- Peto J, Easton OF, Matthews FE, et al. "Cancer mortality in relatives of women with breast
cancer, the OPCS study." Int.]. Cancer 65 (1996): 275-283.
- Colditz GA, Willett W, Hunter OJ, et at. "Family history, age, and risk of breast cancer. Pro-
spective data from the Nurses' Health Study." lAMA 270 (1993): 338-343.
- National Human Genome Research Institute. "Learning About Breast Cancer." Accessed at
http://www.genome.gov/l0000507#ql
- Futreal PA, Liu Q , Shattuck-Eidens 0 , et al. "BRCAI mutations in primary breast and ovarian
carcinomas." Science 266 (1994): 120-122.
- Miki Y, SwensenJ, Shatttuck-Eidens 0, et al. "A strong candidate for the breast and ovarian
cancer susceptibility gene BRCA1." Science 266 (1994): 66--71.
- Wooster R, Bignell G, Lancaster J, et al. "Identification ofthe breast cancer susceptibility gene
BRCA2." Nature 378 (1995): 789-792.
- Tavtigian Sv, Simard J , Rommens J, et al. "The complete BRCA2 gene and mutations in chro-
mosome 13q-linked kindreds." Nat. Genet. 12 (1996): 333-337.
- Ford 0, Easton 0, Bishop DT, et al. "Risks of cancer in BRCAI mutation carriers." Lancet 343
(1994): 692-695.
- Antoniou A, Pharoah PDp, Narod S, et at. "Average risks of breast and ovarian cancer associ-
ated with BRCAI or BRCA2 mutations detected in case series unselected for family history: a
combined analysis of 22 studies." Am. ]. Hum. Genet. 72 (2003): 1117-1130.
- Newman B, Mu H, Butler LM, et al. "Frequency of breast cancer attributable to BRCAI in a
population-based series of American women." lAMA 279 (1998): 915-921.
- Peto], Collins N, Barfoot R, et al. "Prevalence of BRCAI and BRCA2 gene mutations in pa-
tients with early-onset breast cancer."]. Nat. Cancer Inst. 91 (1999): 943-949.
- Tabar L, Fagerberg G, Chen HH, et al. "Efficacy of breast cancer screening by age. New results
from the Swedish Two-County Trial." Cancer 75 (1995): 2507-2517.
- Bjurstram N, Bjomeld L, Duffy Sw, et a1. "The Gothenburg Breast Cancer Screening Trial:
first results on mortality, incidence, and mode of detection for women ages 39-49 years at
randomization." Cancer 80 (1997): 2091-2099.
- Frisell J, Lidbrink E, Hellstrom L, et at. "Follow-up after 11 years: update of mortality results
in the Stockholm mammographic screening trial." Breast Cancer Res. Treat 199745 (1997):
263-270.
- Greenlee RT, Hill-Harmon MB, Murray T, et at. "Cancer statistics, 2001." CA Cancer]. Clin.
51 (2001): 15-36.
